Literature DB >> 3829366

Occupational asthma in nurses handling psyllium.

A Cartier, J L Malo, J Dolovich.   

Abstract

Five nurses aged 31-55 years old had a history of asthmatic symptoms after being exposed to psyllium that they prepared and distributed to patients. They had been nurses for 9-20 years and had reported asthmatic symptoms related to work in the past 3-12 months. They reported symptoms of rhinoconjunctivitis and all were atopic but only one had a previous history of asthma. Four of the five tested subjects had an immediate skin reaction to a commercial psyllium extract. All had IgE antibodies to psyllium. At the time that they were investigated, four out of the five had a significant increase in bronchial responsiveness to methacholine (PC 20 less than 8 mg/ml). Inhalation challenges with psyllium caused isolated immediate (one subject) and dual reactions (three subjects). One subject exposed for only 1 min to the psyllium powder experienced a severe immediate bronchospastic reaction, which required intubation for 3 h with complete functional recovery thereafter. This experience illustrates the precautions necessary, with the inclusion of a cautious dose-response approach, even with an 'occupation-type' challenge in the laboratory.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829366     DOI: 10.1111/j.1365-2222.1987.tb02313.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  3 in total

1.  Occupational asthma among hospital health care personnel: a cause for concern?

Authors:  J P Hayes; M X Fitzgerald
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

2.  New methodology for specific inhalation challenges with occupational agents.

Authors:  Simon Caron; Jean-Christian Boileau; Jean-Luc Malo; Simon Leblond
Journal:  Respir Res       Date:  2010-06-09

3.  Occupational asthma in a pharmaceutical worker exposed to hydralazine.

Authors:  B Perrin; J L Malo; A Cartier; S Evans; J Dolovich
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.